BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

Nifty500 LargeMidSmall Equal-Cap Weighted Index

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty500 LargeMidSmall Equal-Cap Weighted Index Performance

Day's Range

Low

₹18,728.40

High

₹18,831.80

52 Week Range

Low

₹15,495.10

High

₹18,831.80

Previous Close ₹18,760.80
Day's Range ₹18,728.40 - ₹18,831.80
Open ₹18,778.90
52 Week Range ₹15,495.10 - ₹18,831.80
Volume 2,19,44,64,438

Nifty500 LargeMidSmall Equal-Cap Weighted Index Companies

Company Name LTP (₹) Change (₹) Sector
ABB India Ltd. 7649.50 Arrow 49.50 (0.65%) Capital Goods
Aegis Logistics Ltd. 1333.70 Arrow -37.30 (-2.72%) Trading
Amara Raja Energy & Mobility Ltd. 897.70 Arrow -34.00 (-3.65%) Automobile & Ancillaries
Atul Ltd. 6854.00 Arrow 80.00 (1.18%) Chemicals
Force Motors Ltd. 18300.00 Arrow -200.00 (-1.08%) Automobile & Ancillaries
Bajaj Finance Ltd. 1102.20 Arrow 24.20 (2.24%) Finance
Balrampur Chini Mills Ltd. 655.25 Arrow 21.80 (3.44%) Agri
Aditya Birla Real Estate Ltd. 1393.20 Arrow 10.40 (0.75%) Realty
BASF India Ltd. 4031.60 Arrow -59.40 (-1.45%) Chemicals
Bata India Ltd. 712.85 Arrow -7.65 (-1.06%) FMCG

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 24583.8 26373.20 22182.55
Nifty IT 31631.45 40301.40 25699.10
Nifty Next 50 74766.85 74860.10 59896.10
NIFTY50 USD Index 8938.95 10443.40 8132.40
Nifty Bank 57686.95 61764.85 49954.85
NIFTY Midcap 100 63855.7 63986.70 52032.85
Nifty 500 23743.2 24144.20 20385.65
Nifty Midcap 50 18298.9 18336.75 14804.55
Nifty 100 25728.3 26975.15 22720.45
Nifty FMCG 49363.6 58485.05 45334.15

Latest News

Aug
10
2026
EQUITY Posted on Aug 10th 2026

Glenmark Pharmaceuticals informs about allotment of shares under ESOP

Glenmark Pharmaceuticals has informed that the Company has allotted 23,863 Equity Shares of Re 1 each on August 10, 2026, to the grantee who had exercised the options under the Company's Employee Stock Option Plan 2016 (ESOP 2016). With this allotment, the paid-up capital of the Company has increased from Rs 28,22,00,809 divided into 28,22,00,809 number of equity shares of face value Re 1 each to Rs. 28,22,24,672 divided into 28,22,24,672 number of equity shares of face value Re 1 each. The details as required under the SEBI (Share Based Employee Benefits and Sweat equity) Regulations, 2021 are enclosed as Annexure - I.

The above information is a part of company’s filings submitted to BSE.  

Read More
Aug
10
2026
EQUITY Posted on Aug 10th 2026

Akums Drugs and Pharmaceuticals informs about newspaper advertisements

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals has informed that it enclosed copies of the newspaper advertisements published on August 09, 2026 in the newspapers: Financial Express (English -New Delhi Edition) and Jansatta (Hindi - New Delhi Edition). The advertisements contain a Quick Response (QR) Code enabling direct access to the unaudited (Standalone & Consolidated) Financial Results of the company for the quarter ended June 30, 2026 as approved by the Board of Directors at its meeting held on August 08, 2026. A copy of this disclosure is being updated on the website of the Company at www.akums.in. 

The above information is a part of company’s filings submitted to BSE. 

Read More
Aug
10
2026
EQUITY Posted on Aug 10th 2026

Mahindra & Mahindra Financial Services informs about analyst meet

In compliance with Regulation 30(6), Schedule III, Part A, Para A(15) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Mahindra & Mahindra Financial Services has informed that Emkay Confluence 2026 will be held on Thursday, 13th August 2026 at 10:00 am to 1:00 pm (IST), which would be attended by the Company Officials, further details are enclosed. No Unpublished Price Sensitive Information is proposed to be shared by the Company during the aforesaid investor conference(s). The ensuing discussions at the aforesaid investor conference(s) would include reference to the business/quarterly updates and earnings presentation for Q1 FY2027 sent by the Company to the Stock Exchanges vide its letters dated 2nd July 2026 and 21st July 2026, respectively, and general business overview. In compliance with Regulation 46(2) of the SEBI Listing Regulations, this disclosure is being hosted on the website of the Company at URL: https://www.mahindrafinance.com/investor-relations/financialinformation#schedule-of-analysts-investor-meets.

The above information is a part of company’s filings submitted to BSE. 
Read More
Aug
10
2026
EQUITY Posted on Aug 10th 2026

Birlasoft informs about analyst meet

Birlasoft has informed that the Company is participating in investor meetings at the investor conferences, as on August 13, 2026 and August 14, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
10
2026
EQUITY Posted on Aug 10th 2026

Leela Palaces Hotels & Resorts informs about acquisition

Pursuant to Regulation 30 of the LODR Regulations read with the SEBI Master Circular issued thereunder, Leela Palaces Hotels & Resorts has proposed an investment of up to INR 185,00,00,000 (Rupees One Hundred and Eighty-Five Crores Only), in one or more tranches over one or more years, in Buildminds, a subsidiary of the Company, by way of subscription to Compulsorily Convertible Preference Shares (CCPS). Buildminds is engaged in the development of its upcoming 5-star Hotel at Ayodhya. The proposed investment forms part of the Company's overall commitment to fund the capital requirements of Buildminds and is intended to support its ongoing business operations, project development activities and long-term growth plans. The investment shall be made in one or more tranches, depending upon the funding requirements. Being an investment in an existing subsidiary this will not result in any change in the management control or any economic interest in Buildminds. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NIF500LGMIDSML index?

The previous close of NIF500LGMIDSML index is ₹18789.55 as of 2026-08-10.

The total volume of NIF500LGMIDSML index is 2181933869.00 as of 2026-08-10.

The percentage change in value of NIF500LGMIDSML index is 0.15% as of 2026-08-10.

The absolute increase in NIF500LGMIDSML index value since the previous trading day is ₹28.75 as of 2026-08-10.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore